Page last updated: 2024-12-06

benzydamine n-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzydamine N-oxide: RN given refers to parent cpd; structure given in first source; metabolite of benzydamine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65465
MeSH IDM0140368

Synonyms (11)

Synonym
benzydamine n-oxide
3-(1-benzylindazol-3-yl)oxy-n,n-dimethylpropan-1-amine oxide
FT-0662622
FT-0662623
1-propanamine, n,n-dimethyl-3-((1-(phenylmethyl)-1h-indazol-3-yl)oxy)-, n-oxide
36504-71-9
DTXSID90190005
AKOS030242013
3-((1-benzyl-1h-indazol-3-yl)oxy)-n,n-dimethylpropan-1-amine oxide
CS-0646597
HY-N11425

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Simulations of human plasma concentrations of benzydamine and its N-oxide were achieved using simplified physiologically based pharmacokinetic models based on data from control TK-NOG mice and from reported benzydamine concentrations after low-dose administration in humans."( Human plasma metabolic profiles of benzydamine, a flavin-containing monooxygenase probe substrate, simulated with pharmacokinetic data from control and humanized-liver mice.
Mitsui, M; Nishiwaki, M; Shimizu, M; Suemizu, H; Yamazaki, H; Yamazaki-Nishioka, M, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" In addition, the confirmed low bioavailability of the drugs excludes the possibility of any accumulation effects and limits the risk of undesired systemic effects."( Phase I Study in Healthy Women of a Novel Antimycotic Vaginal Ovule Combining Econazole and Benzydamine.
Bovi, G; Caccia, G; Comandini, A; Di Stefano, AFD; Focanti, F; Olivieri, S; Pelacchi, F; Picollo, R; Radicioni, MM; Rosignoli, MT; Salvatori, E; Vaccani, A, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.76 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]